<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>267754</rcn>
  <id>101188322</id>
  <acronym>UbiHealth</acronym>
  <teaser>Biotechnology startup Altratech Ltd was founded with the vision to transform molecular diagnostics through nanotechnology. Wehave developed and patented a novel technology for molecular testing of viruses and pathogens in non-clinical environments. Thisall-synthetic novel...</teaser>
  <objective>Biotechnology startup Altratech Ltd was founded with the vision to transform molecular diagnostics through nanotechnology. We
have developed and patented a novel technology for molecular testing of viruses and pathogens in non-clinical environments. This
all-synthetic novel assay can detect and quantify DNA, RNA, Antibody, and Antigen molecular targets, from blood or saliva samples, in
20 mins, without any need of centrifuges or pipettes. This will enable market-disrupting products that have the simplicity of a
pregnancy test and the performance of a laboratory PCR test.
All molecular diagnostic systems today require biological amplification, i.e., polymerase chain reaction (PCR), Loop-mediated
polymerase amplification (LAMP), or similar. This takes time, and requires trained personnel, refrigeration for enzymes, and specialised
equipment for heating/cooling and optical detection. It is because of these requirements that there is no solution on the market
today for the non-clinical detection, monitoring, and management of viral infections such as HIV, Hepatitis, Influenza, Malaria,
Meningitis, Shingles, Dengue Fever, HPV, EBV-related cancers, and many more.
Our solution is a molecular detection process that eliminates the requirement for biological amplification and optical detection. We
have invented and patented the key breakthrough of detecting and quantifying genetic material, viruses, and pathogens using
almost instant electronic signal amplification, with semiconductor sensing and digital readout.
The Value Proposition to our target customers, who will be the worlds leading diagnostic companies, is the ability to licence a novel
patent protected product, with a wider range of market applications compared to their current diagnostic products. This will
facilitate their entry into new markets and increase gross margins in existing markets.
This innovation will impact the 48B Diagnostics industry.</objective>
  <title>Transforming Molecular Diagnostics through NanoTechnology</title>
  <keywords>eHealth, Digital Health, Bioinformatics, virology, wellbeing, Telemedicine, CMOS, Semiconductors, Electronics,  Communication technology</keywords>
  <totalCost>0</totalCost>
  <ecMaxContribution>2499999</ecMaxContribution>
  <startDate>2024-12-01</startDate>
  <endDate>2026-11-30</endDate>
  <ecSignatureDate>2024-11-20</ecSignatureDate>
  <duration>24</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/101188322</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2024-12-31 09:30:22</sourceUpdateDate>
  <contentCreationDate readOnly="true">2024-12-12 11:00:11</contentCreationDate>
  <contentUpdateDate>2024-12-12 11:00:10</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-09-19 14:48:37</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56829</rcn>
        <title>HORIZON-EIC-2024-ACCELERATOR-02</title>
        <identifier>HORIZON-EIC-2024-ACCELERATOR-02</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56829</rcn>
        <title>HORIZON-EIC-2024-ACCELERATOR-02</title>
        <identifier>HORIZON-EIC-2024-ACCELERATOR-02</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="2499999" terminated="false" sme="true" netEcContribution="2499999" totalCost="0" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>2350949</rcn>
        <id>939703021</id>
        <vatNumber>IE3227725QH</vatNumber>
        <legalName>ALTRATECH LIMITED</legalName>
        <shortName>ALTRATECH LIMITED</shortName>
        <address>
          <street>4TH FLOOR 103/104 O CONNELL STREET</street>
          <city>Limerick</city>
          <postalCode>V94  AT85</postalCode>
          <country>IE</country>
          <geolocation>52.7110462,-8.882715</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Mid-West </name>
              <rcn>1464303</rcn>
              <nutsCode>IE051</nutsCode>
              <parents>
                <region>
                  <name>Southern</name>
                  <rcn>1464993</rcn>
                  <nutsCode>IE05</nutsCode>
                  <parents>
                    <region>
                      <name>Ireland</name>
                      <rcn>305662504</rcn>
                      <nutsCode>IE0</nutsCode>
                      <parents>
                        <region>
                          <name>Ireland</name>
                          <rcn>305826344</rcn>
                          <nutsCode>IE</nutsCode>
                          <euCode>IE</euCode>
                          <isoCode>IE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Ireland</name>
              <rcn>305826344</rcn>
              <nutsCode>IE</nutsCode>
              <euCode>IE</euCode>
              <isoCode>IE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>708772</rcn>
        <id>HORIZON_HORIZON-EIC-2024-ACCELERATOROPEN-01</id>
        <code>HORIZON-EIC-2024-ACCELERATOROPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Accelerator Open 2024</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/621</code>
        <title>malaria</title>
        <displayCode readOnly="true">/medical and health sciences/health sciences/infectious diseases/malaria</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/25/69</code>
        <title>nanotechnology</title>
        <displayCode readOnly="true">/engineering and technology/nanotechnology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/44109686/71336944</code>
        <title>influenza</title>
        <displayCode readOnly="true">/medical and health sciences/health sciences/infectious diseases/RNA viruses/influenza</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/44109686/619</code>
        <title>HIV</title>
        <displayCode readOnly="true">/medical and health sciences/health sciences/infectious diseases/RNA viruses/HIV</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/25/57/375/1141</code>
        <title>laboratory samples analysis</title>
        <displayCode readOnly="true">/engineering and technology/medical engineering/medical laboratory technology/laboratory samples analysis</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC-ACC</code>
        <title>HORIZON EIC Accelerator</title>
        <displayCode readOnly="true">/HORIZON EIC Accelerator</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
